NASDAQ:EKSO - Nasdaq - US2826443010 - Common Stock - Currency: USD
Taking everything into account, EKSO scores 2 out of 10 in our fundamental rating. EKSO was compared to 187 industry peers in the Health Care Equipment & Supplies industry. EKSO may be in some trouble as it scores bad on both profitability and health. EKSO has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -39.52% | ||
ROE | -85.03% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 53.39% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.28 | ||
Debt/FCF | N/A | ||
Altman-Z | -9.47 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.35 | ||
Quick Ratio | 1.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:EKSO (6/25/2025, 3:40:32 PM)
3.15
+0.09 (+2.94%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 5.21 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 7.21 | ||
P/tB | 11.52 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -39.52% | ||
ROE | -85.03% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 53.39% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.28 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 2.47% | ||
Cap/Sales | 0.22% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.35 | ||
Quick Ratio | 1.77 | ||
Altman-Z | -9.47 |